Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

STOK Stoke Therapeutics, Inc.

盘前交易 09-18 04:04:40 EDT

15.12

+0.40

+2.72%

最高15.36	最低14.64	成交量93.91万
今开14.77	昨收14.72	日振幅4.89%
总市值7.96亿	流通市值4.80亿	总股本5,265万
成交额1,411万	换手率2.96%	流通股本3,177万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"STOK","market":"US","secType":"STK","nameCN":"Stoke Therapeutics, Inc.","latestPrice":15.12,"timestamp":1726603200000,"preClose":14.72,"halted":0,"volume":939108,"delay":0,"floatShares":31765697,"shares":52647799,"eps":-2.159691,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.4,"latestTime":"09-18 04:04:40 EDT","open":14.77,"high":15.36,"low":14.64,"amount":14105529.878688,"amplitude":0.048913,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.159691,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726666200000},"adr":0,"listingDate":1560916800000,"adjPreClose":15.12,"postHourTrading":{"tag":"盘后","latestPrice":15.12,"preClose":15.12,"latestTime":"17:38 EDT","volume":499958,"amount":7559364.96,"timestamp":1726609118000},"volumeRatio":1.130662050865129,"impliedVol":0.6625,"impliedVolPercentile":0.1833},"requestUrl":"/m/hq/s/STOK","defaultTab":"news","newsList":[{"id":"2459192210","title":"Stoke Therapeutics, Inc.盘中异动 大幅上涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459192210","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459192210?lang=zh_cn&edition=full","pubTime":"2024-08-16 22:05","pubTimestamp":1723817132,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日22时05分，Stoke Therapeutics, Inc.股票出现波动，股价快速上涨5.25%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Cingulate Inc.、Cingulate Inc C/Wts 10/12/2026 、Seelos Therapeutics, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为4136.29%、1514.94%、171.44%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Seelos Therapeutics, Inc.，振幅分别为100.53%、41.25%、36.81%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816220533a1d4aee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816220533a1d4aee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STOK","BK4139","LENZ"],"gpt_icon":0},{"id":"2458682512","title":"Stoke Therapeutics, Inc.2024财年第二财季实现净利润-25.70百万美元，同比增加16.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458682512","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458682512?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:19","pubTimestamp":1723306787,"startTime":"0","endTime":"0","summary":"8月11日，Stoke Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-25.70百万美元，同比增加16.15%；其中营业收入为4.83百万美元，同比增加294.76%，每股基本收益为-0.46美元。机构评级：截至2024年8月11日，当前有7家机构对Stoke Therapeutics, Inc.目标价做出预测，其中目标均价为22.14美元，其中最低目标价为14.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001958958e7540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811001958958e7540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","STOK"],"gpt_icon":0},{"id":"1148942632","title":"异动解读 | Stoke Therapeutics股价大涨5.36% 分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1148942632","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148942632?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:06","pubTimestamp":1723190811,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics, Inc.(STOK)今日盘中股价大涨5.36%,报收于14.45美元。公司主要从事基于RNA的药物研发,旨在通过上调蛋白质表达来治疗严重疾病。\n\n分析人士认为,该股价大涨或与投资者对公司前景的乐观预期有关。公司旗舰产品STK-001正在进行临床试验,用于治疗Dravet综合征(一种严重的遗传性癫痫)。如果临床试验取得成功,将为公司带来重大利好。\n\n此外,生物技术行业整体今日表现不俗,也为Stoke Therapeutics股价上涨带来了有利因素。数据显示,公司所在的生物技术行业今日整体上涨2.5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK"],"gpt_icon":0},{"id":"2457310888","title":"Stoke Therapeutics, Inc.盘中异动 股价大涨5.40%报14.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457310888","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457310888?lang=zh_cn&edition=full","pubTime":"2024-08-08 22:36","pubTimestamp":1723127786,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日22时36分，Stoke Therapeutics, Inc.股票出现异动，股价急速上涨5.40%。截至发稿，该股报14.45美元/股，成交量5.3989万股，换手率0.10%，振幅4.08%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.50%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808223626af96a0ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808223626af96a0ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","STOK"],"gpt_icon":0},{"id":"2457849555","title":"斯托克治疗公司（Stoke Therapeutics Inc）公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457849555","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457849555?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:26","pubTimestamp":1723037210,"startTime":"0","endTime":"0","summary":"   * Stoke Therapeutics Inc   报告，截至6月底的季度调整后每股亏损46美分，高于去年同期的每股-69美分。九位分析师对该季度的平均预期是每股亏损 56 美分。华尔街预期为每股-65美分至-45美分。* 营收同比增长 294.7%，达到 483 万美元；分析师预期为 326 万美元。* Stoke Therapeutics 公司公布的本季度每股收益为亏损 46 美分。* 该公司的季度亏损额为 2570 万美元。* Stoke Therapeutics Inc的股价本季度上涨了5.3%，今年迄今为止上涨了170.5%。华尔街对 Stoke Therapeutics Inc 的 12 个月目标价中位数为 21.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","STOK"],"gpt_icon":0},{"id":"2457077290","title":"Stoke Therapeutics, Inc.盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457077290","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457077290?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:29","pubTimestamp":1722968992,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日02时29分，Stoke Therapeutics, Inc.股票出现异动，股价快速上涨5.01%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.15%。其相关个股中，Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1417.85%、1385.45%、529.31%，振幅较大的相关个股有Vbi Vaccines, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Alpha Tau Medical Ltd C/Wts ，振幅分别为168.52%、81.76%、78.49%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807022952941feaec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807022952941feaec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STOK","LENZ","BK4139"],"gpt_icon":0},{"id":"2456234273","title":"Stoke Therapeutics Inc   预计每股亏损 56 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456234273","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456234273?lang=zh_cn&edition=full","pubTime":"2024-08-03 00:17","pubTimestamp":1722615435,"startTime":"0","endTime":"0","summary":"   * Stoke Therapeutics Inc    预计将在8月5日公布截至2024年6月30日的业绩(估计)，季度收入将有所增长。* 根据LSEG的数据，9位分析师的平均预期显示，这家总部位于马萨诸塞州贝德福德的公司的营收预计将从去年同期的248万美元下降231.2%，至325.6万美元。* LSEG 分析师对 Stoke Therapeutics Inc 的平均预期是每股亏损 56 美分。* 华尔街对 Stoke Therapeutics Inc 的 12 个月目标价中位数为 21.00 美元，高于其最新收盘价 14.72 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","STOK"],"gpt_icon":0},{"id":"2455155428","title":"Stoke Therapeutics, Inc.盘中异动 大幅拉升5.14%报15.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455155428","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455155428?lang=zh_cn&edition=full","pubTime":"2024-07-31 23:01","pubTimestamp":1722438070,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日23时01分，Stoke Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Renovaro Inc.、Applied Therapeutics, Inc.、Zevra Therapeutics, Inc.涨幅较大，Bionomics Ltd Ads Each Rep 180 Ord Shs、Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为135.36%、116.63%、113.03%，振幅较大的相关个股有Renovaro Inc.、Salarius Pharmaceuticals, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs，振幅分别为79.10%、40.61%、37.17%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731230111941fca02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731230111941fca02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STOK","LENZ","BK4139"],"gpt_icon":0},{"id":"2455669106","title":"Stoke Therapeutics, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455669106","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455669106?lang=zh_cn&edition=full","pubTime":"2024-07-29 22:15","pubTimestamp":1722262558,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日22时15分，Stoke Therapeutics, Inc.股票出现异动，股价大幅下跌5.04%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.涨幅较大，Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Palisade Bio, Inc.较为活跃，换手率分别为1739.03%、192.34%、156.83%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为128.68%、75.11%、57.78%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072922155996821392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072922155996821392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","STOK"],"gpt_icon":0},{"id":"2454218623","title":"Stoke Therapeutics, Inc.盘中异动 急速上涨5.08%报15.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454218623","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454218623?lang=zh_cn&edition=full","pubTime":"2024-07-26 23:09","pubTimestamp":1722006594,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日23时09分，Stoke Therapeutics, Inc.股票出现异动，股价大幅拉升5.08%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Windtree Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为5188.97%、174.58%、107.04%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Windtree Therapeutics, Inc.、Sangamo Therapeutics, Inc.，振幅分别为132.50%、86.32%、66.22%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726230955af945bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726230955af945bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","STOK","LENZ"],"gpt_icon":0},{"id":"2454877623","title":"Stoke Therapeutics, Inc.盘中异动 早盘急速上涨5.22%报15.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454877623","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454877623?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:18","pubTimestamp":1721917092,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时18分，Stoke Therapeutics, Inc.股票出现波动，股价急速拉升5.22%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2079.71%、414.82%、162.85%，振幅较大的相关个股有Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为114.90%、98.60%、82.05%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072522181296820549&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072522181296820549&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","STOK"],"gpt_icon":0},{"id":"2453716100","title":"Stoke Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453716100","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453716100?lang=zh_cn&edition=full","pubTime":"2024-07-23 01:53","pubTimestamp":1721670817,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日01时53分，Stoke Therapeutics, Inc.股票出现波动，股价大幅拉升5.08%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Apollomics Inc C/Wts 01/04/2028 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为122.14%、113.28%、70.72%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学，振幅分别为44.07%、37.06%、33.41%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230153379681ef05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230153379681ef05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","STOK"],"gpt_icon":0},{"id":"2433786337","title":"加拿大投资银行集团：维持Stoke Therapeutics(STOK.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433786337","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433786337?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:25","pubTimestamp":1715091952,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Stoke Therapeutics(STOK.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072225578ae54144&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072225578ae54144&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","STOK"],"gpt_icon":0},{"id":"2433262884","title":"Stoke Therapeutics(STOK.US)：2024年Q1财报实现营收421.6万美元，前值为551.2万美元，预期值为321万美元；","url":"https://stock-news.laohu8.com/highlight/detail?id=2433262884","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433262884?lang=zh_cn&edition=full","pubTime":"2024-05-06 19:19","pubTimestamp":1714994377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","STOK"],"gpt_icon":0},{"id":"2432377875","title":"Stoke Therapeutics Inc   预计每股亏损61美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432377875","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432377875?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:17","pubTimestamp":1714493843,"startTime":"0","endTime":"0","summary":"   * Stoke Therapeutics Inc    预计将在5月2日公布截至2024年3月31日的业绩(估计)，季度收入将出现下降。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于马萨诸塞州贝德福德的公司的营收预计将从去年同期的515万美元下降37.6%，至321.4万美元。* LSEG 分析师对 Stoke Therapeutics Inc 的平均预期是每股亏损 61 美分。* 华尔街对 Stoke Therapeutics Inc 的 12 个月目标价中位数为 21.50 美元，高于其最新收盘价 11.86 美元。4月30日 - 以往季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK","LENZ"],"gpt_icon":0},{"id":"2427833065","title":"Stoke Therapeutics, Inc.盘中异动 临近收盘股价大跌5.40%报12.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427833065","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427833065?lang=zh_cn&edition=full","pubTime":"2024-04-16 03:55","pubTimestamp":1713210950,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日03时55分，Stoke Therapeutics, Inc.股票出现异动，股价急速跳水5.40%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1740.30%、1265.91%、910.77%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、124.89%、80.04%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416035550861e5e36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416035550861e5e36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","STOK"],"gpt_icon":0},{"id":"2426292785","title":"Stoke Therapeutics, Inc.盘中异动 股价大涨5.17%报13.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426292785","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426292785?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:47","pubTimestamp":1712864869,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时47分，Stoke Therapeutics, Inc.股票出现波动，股价急速拉升5.17%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。该信息摘要如下：Needham：重申Stoke Therapeutics评级，由买入调整至买入评级, 目标价22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120347497a52322b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120347497a52322b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","STOK","LENZ"],"gpt_icon":0},{"id":"2426923416","title":"Needham：重申Stoke Therapeutics(STOK.US)评级，由买入调整至买入评级, 目标价22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426923416","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426923416?lang=zh_cn&edition=full","pubTime":"2024-04-11 18:14","pubTimestamp":1712830480,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LENZ","STOK"],"gpt_icon":0},{"id":"2426119830","title":"Stoke Therapeutics, Inc.盘中异动 股价大跌5.46%报12.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426119830","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426119830?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:54","pubTimestamp":1712674447,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时54分，Stoke Therapeutics, Inc.股票出现波动，股价大幅下挫5.46%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Acrivon Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为439.46%、104.03%、67.41%，振幅较大的相关个股有Biophytis、Mymd Pharmaceuticals, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为39.96%、33.85%、23.31%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409225407791f6d4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409225407791f6d4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","STOK","LENZ"],"gpt_icon":0},{"id":"2425676385","title":"Stoke Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425676385","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2425676385?lang=zh_cn&edition=full","pubTime":"2024-04-05 23:20","pubTimestamp":1712330456,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日23时20分，Stoke Therapeutics, Inc.股票出现异动，股价快速拉升5.01%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。消息层面，截至23时20分，《Form 144 | Stoke Therapeutics高管拟出售9,426股股份，价值约12.73万美元》资讯为影响Stoke Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405232057861e390a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405232057861e390a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","STOK","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.stoketherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0503},{"period":"1month","weight":0.0335},{"period":"3month","weight":0.0033},{"period":"6month","weight":1.5242},{"period":"1year","weight":2.1966},{"period":"ytd","weight":1.8745}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Stoke Therapeutics, Inc.成立于2014年6月，根据特拉华州法律注册成立。该公司是一家早期生物制药公司，通过精确上调蛋白质表达，开创了治疗严重遗传疾病根本原因的新方法。他们正在开发新的反义寡核苷酸，或ASO，针对核糖核酸或RNA，调节前体的药物-作用RNA或前mRNA，剪接以在需要时上调蛋白质表达并且具有接近正常水平的适当特异性。他们利用其专有技术平台，核基因输出的靶向增强或TANGO，设计ASO以通过患者中的个体基因上调蛋白质的表达。他们的方法旨在以高度精确，持久和受控的方式向广泛的相关组织（包括中枢神经系统或中枢神经系统，眼睛，肾脏和肝脏）提供疾病改善疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.047456},{"month":2,"riseRate":0.4,"avgChangeRate":0.077295},{"month":3,"riseRate":0.4,"avgChangeRate":0.066891},{"month":4,"riseRate":0.2,"avgChangeRate":-0.135958},{"month":5,"riseRate":0.8,"avgChangeRate":0.193418},{"month":6,"riseRate":0.2,"avgChangeRate":-0.065147},{"month":7,"riseRate":0.5,"avgChangeRate":-0.06589},{"month":8,"riseRate":0.5,"avgChangeRate":0.072738},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.120195},{"month":10,"riseRate":0.6,"avgChangeRate":0.097204},{"month":11,"riseRate":0.4,"avgChangeRate":-0.037094},{"month":12,"riseRate":0.8,"avgChangeRate":0.184055}],"exchange":"NASDAQ","name":"Stoke Therapeutics, Inc.","nameEN":"Stoke Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Stoke Therapeutics, Inc.(STOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Stoke Therapeutics, Inc.,STOK,Stoke Therapeutics, Inc.股票,Stoke Therapeutics, Inc.股票老虎,Stoke Therapeutics, Inc.股票老虎国际,Stoke Therapeutics, Inc.行情,Stoke Therapeutics, Inc.股票行情,Stoke Therapeutics, Inc.股价,Stoke Therapeutics, Inc.股市,Stoke Therapeutics, Inc.股票价格,Stoke Therapeutics, Inc.股票交易,Stoke Therapeutics, Inc.股票购买,Stoke Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Stoke Therapeutics, Inc.(STOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}